logo

For the Inventor, By the Inventor

Hennigsdorf, Germany

Sphingotec Gmbh

Calculating rank
USPTO Granted Patents = 21

% Expired Patents = 9.5



Trademarks = 6

Forward Citations = 74

Loading Chart...
Loading Chart...

4 inventors (with patents filed for the assignee):

goldMedal Andreas Bergmann (20 out of 109 patents)

silverMedal Olle Melander (6 out of 9 patents)

bronzeMedal Andrea Ernst (4 out of 7 patents)

4.  Harald Hampel (1 out of 4 patents)

5.  Andrea Sparwasser (0 patent)

6.  Adriaan Voors (1 patent)

7.  Leong Ng (0 patent)


21 patents:

1. 12399186 - Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction (2025-08-26),
2. 12247988 - Adrenomedullin assays and methods for determining mature andrendomedullin (2025-03-11),
3. 12228581 - Adrenomedullin assays and methods for determining mature andrendomedullin (2025-02-18),
4. 11844812 - Selenoprotein P for prediction of a first cardiovascular event (2023-12-19),
5. 11726101 - Adrenomedullin assays and methods for determining mature adrenomedullin (2023-08-15),
6. 11598781 - Method for predicting the risk of incidence of chronic kidney disease (2023-03-07),
7. 11340240 - Method for predicting the risk of obesity in a subject (2022-05-24),
8. 11067586 - Adrenomedullin assays and methods for determining mature adrenomedullin (2021-07-20),
9. 11016107 - Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction (2021-05-25),
10. 10900978 - Method for predicting the risk of obesity in a subject (2021-01-26),
11. 10605812 - Method for predicting the risk of getting cancer or diagnosing cancer in a subject (2020-03-31),
12. 10598674 - Adrenomedullin to guide therapy of blood pressure decline (2020-03-24),
13. 10520512 - Method for predicting the risk of a subject for contracting diabetes mellitus and/or metabolic syndrome or for diagnosing metabolic syndrome in a subject (2019-12-31),
14. 10114029 - Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction (2018-10-30),
15. 9702876 - Method for predicting the risk of getting cancer or diagnosing cancer in a female subject (2017-07-11),
Company Overview
Sphingotec GmbH is a biotechnology company based in Hennigsdorf, Germany, specializing in the development of innovative diagnostic solutions. The company focuses on biomarker research and the creation of advanced assays for various medical applications, particularly in the fields of cardiology and critical care. By leveraging cutting-edge technology, Sphingotec aims to enhance patient outcomes through early and accurate disease detection, positioning itself as a key player in the evolving landscape of personalized medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

21 Patents

#2 in Hennigsdorf

#2,135 in Germany

#30,018 in the World

Hennigsdorf, DE
Hennigsdorf, Germany

Sphingotec Gmbh

Forward Citations = 74

4 inventors:

goldMedal Andreas Bergmann (20 out of 109 patents)

silverMedal Olle Melander (6 out of 9 patents)

bronzeMedal Andrea Ernst (4 out of 7 patents)

4.  Harald Hampel (1 out of 4 patents)

5.  Andrea Sparwasser (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sphingotec Gmbh. Retrieved from https://idiyas.com/company/sphingotec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…